Computational Biology
Group Leader:
Crispin Miller
The Computational Biology group is focused on using data-driven approaches from AI and machine learning to develop a better understanding of the processes that underpin tumour growth and development. We are a highly collaborative and interdisciplinary group that integrates computer science, mathematics, bench- and clinical science.
A major aspect of our work is the integration of deep-tissue phenotyping datasets captured using our Advanced Technologies – ranging from microscopy, through whole genome-, bulk- and single cell RNA sequencing, spatial transcriptomics, to multiplexed immunofluorescence and hematoxylin and eosin (H&E) stained tissue. These datasets are large enough to use AI and machine learning algorithms that seek to correlate patterns with phenotype. This is allowing us to explore aspects of tumour evolution, and to ask how the regulatory systems that control gene expression are perturbed in tumour cells. One of our goals is to use data to ‘disease position’ our preclinical models of disease against stratified patient cohorts. In this way we can ask how our discovery science datasets capture the heterogeneity of the disease and use our multimodal datasets to identify the best models to represent different patient subsets.
Our group is particularly interested in the regulatory pathways that act downstream of transcription, including the processes that regulate protein translation and stability. Other projects in the group focus on uncovering novel regulatory sequences within the genome, and in making use of comparative genomics to help interpret the genome rearrangements that occur in tumour cells.
Our research includes the development and finetuning of AI foundation models, and we make extensive use of our local HPC facility as well as national supercomputing resources.
We have an internship scheme with STFC DiRAC to support members of the physics and astronomy community interested in bringing their skills to bear upon critical problems in cancer research. The size and complexity of our data require sophisticated approaches to manage, share and compute with them. The Data Science and Data Management Advanced Technology Team is building a FAIR-compliant data platform to support this.

Lab Reports

Recent Publications

Lab Members
Recent Publications
2026
White M., Mills M.L., Millett L.M., Gilroy K., Hong Y., Zeiger L.B., Simpson R.J., Corry S.M., Ligeza A., Lannagan T.R.M., Susanti S., Ridgway R.A., Yazgili A.S., Grzesiak L., Amirkhah R., Ford C.A., Vlahov N., Tovell H., Officer-Jones L., Ficken C., Pennie R., Najumudeen A.K., Raven A., Nasreddin N., Chauhan E., Papanastasiou A.S., Nixon C., Morrison V., Jackstadt R., Graham J.S., Miller C.J., Ross S.J., Barry S.T., Pavet V., Wilson R.H., Le Quesne J., Dunne P.D., Tejpar S., Leedham S., Campbell A.D., Sansom O.J. MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance (2026) Nature, 650 (8102), pp. 748 – 758 DOI: 10.1038/s41586-025-09916-w
Raven A., Gilroy K., Jin H., Waldron J.A., Leslie H., Munro J., Hall H., Ridgway R.A., Ford C.A., Gulhan D.C., Vlahov N., Mills M.L., Hartley A., Anderson E., Bryson S., Sphyris N., Müller M., May S., Cadden B., Nixon C., Waddell S.H., Guest R., Boulter L., Barker N., Clevers H., Zhu H., Ivaska J., Strathdee D., Miller C.J., Jamieson N.B., Bushell M., Park P.J., Bird T.G., Sansom O.J. Hepatic zonation determines tumorigenic potential of mutant β-catenin (2026) Nature, 649 (8097), pp. 739 – 748 DOI: 10.1038/s41586-025-09733-1
Kanellos G., Giacomelli C., Raven A., Vlahov N., Jin H., Herviou P., Malla S.B., Nasreddin N., Centeno P.P., Alexandrou C., Gilroy K., Baird R.L., Pennel K., Munro J., Waldron J.A., Hall H., Officer-Jones L., Bryson S., Strathdee D., Lilla S., Zanivan S., Morrison V., Nixon C., Ridgway R.A., Miller C., Knight J.R.P., Campbell A.D., Dunne P.D., Le Quesne J., Edwards J., Park P.J., Bushell M., Sansom O.J. Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation (2026) Nature Genetics, 58 (1), pp. 100 – 115 DOI: 10.1038/s41588-025-02408-7
Riggio A.I., Sweeney K., Shaw R., Lawlor A., Khan A., Ferrari N., Anand J., Galbraith L.C.A., Gilroy K., Bull C., Young A.L., Athineos D., Hall H., Ghaffar F., Hughes M., Mitchell C.A., Mitchell L., Nixon C., Adams P.D., Roberts E.W., Miller C.J., Dunne P.D., Campbell K.J., Cameron E.R., Blyth K. Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis (2026) British Journal of Cancer, 135 (4), pp. 532 – 545 DOI: 10.1038/s41416-026-03439-5
2025
Müller M., May S., Hall H., Kendall T.J., McGarry L., Blukacz L., Nuciforo S., Georgakopoulou A., Jamieson T., Phinichkusolchit N., Dhayade S., Suzuki T., Huguet-Pradell J., Powley I.R., Officer-Jones L., Pennie R.L., Esteban-Fabró R., Gris-Oliver A., Pinyol R., Skalka G.L., Leslie J., Hoare M., Sprangers J., Malviya G., Mackintosh A., Johnson E., McCain M., Halpin J., Kiourtis C., Nixon C., Clark G., Clark W., Shaw R., Hedley A., Drake T.M., Tan E.H., Neilson M., Murphy D.J., Lewis D.Y., Reeves H.L., Le Quesne J., Mann D.A., Carlin L.M., Blyth K., Llovet J.M., Heim M.H., Sansom O.J., Miller C.J., Bird T.G. Human-correlated genetic models identify precision therapy for liver cancer (2025) Nature, 639 (8055), pp. 754 – 764 DOI: 10.1038/s41586-025-08585-z
Liu D., Young F., Lamb K.D., Claudio Quiros A., Pancheva A., Miller C.J., Macdonald C., Robertson D.L., Yuan K. PLM-interact: extending protein language models to predict protein-protein interactions (2025) Nature Communications, 16 (1), art. no. 9012 DOI: 10.1038/s41467-025-64512-w
2024
Malla S.B., Byrne R.M., Lafarge M.W., Corry S.M., Fisher N.C., Tsantoulis P.K., Mills M.L., Ridgway R.A., Lannagan T.R.M., Najumudeen A.K., Gilroy K.L., Amirkhah R., Maguire S.L., Mulholland E.J., Belnoue-Davis H.L., Grassi E., Viviani M., Rogan E., Redmond K.L., Sakhnevych S., McCooey A.J., Bull C., Hoey E., Sinevici N., Hall H., Ahmaderaghi B., Domingo E., Blake A., Richman S.D., Isella C., Miller C., Bertotti A., Trusolino L., Loughrey M.B., Kerr E.M., Tejpar S., Maughan T.S., Lawler M., Campbell A.D., Leedham S.J., Koelzer V.H., Sansom O.J., Dunne P.D. Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer (2024) Nature Genetics, 56 (3), pp. 458 – 472 DOI: 10.1038/s41588-024-01654-5
Wiesheu R., Edwards S.C., Hedley A., Hall H., Tosolini M., Fares da Silva M.G.F., Sumaria N., Castenmiller S.M., Wardak L., Optaczy Y., Lynn A., Hill D.G., Hayes A.J., Hay J., Kilbey A., Shaw R., Whyte D., Walsh P.J., Michie A.M., Graham G.J., Manoharan A., Halsey C., Blyth K., Wolkers M.C., Miller C., Pennington D.J., Jones G.W., Fournie J.-J., Bekiaris V., Coffelt S.B. IL-27 maintains cytotoxic Ly6C<sup>+</sup> γδ T cells that arise from immature precursors (2024) EMBO Journal, 43 (14), pp. 2878 – 2907 DOI: 10.1038/s44318-024-00133-1
2023
Edwards S.C., Hedley A., Hoevenaar W.H.M., Wiesheu R., Glauner T., Kilbey A., Shaw R., Boufea K., Batada N., Hatano S., Yoshikai Y., Blyth K., Miller C., Kirschner K., Coffelt S.B. PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ Tcells (2023) Journal of Experimental Medicine, 220 (2), art. no. e20211431 DOI: 10.1084/jem.20211431
Román-Fernández A., Mansour M.A., Kugeratski F.G., Anand J., Sandilands E., Galbraith L., Rakovic K., Freckmann E.C., Cumming E.M., Park J., Nikolatou K., Lilla S., Shaw R., Strachan D., Mason S., Patel R., McGarry L., Katoch A., Campbell K.J., Nixon C., Miller C.J., Leung H.Y., Le Quesne J., Norman J.C., Zanivan S., Blyth K., Bryant D.M. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function (2023) Science Advances, 9 (5), art. no. eabq1858 DOI: 10.1126/sciadv.abq1858
2022
Freckmann E.C., Sandilands E., Cumming E., Neilson M., Román-Fernández A., Nikolatou K., Nacke M., Lannagan O.J., Miller C.J., Bryant D.M. Traject3d allows label-free identification of distinct co-occurring phenotypes within 3D culture by live imaging (2022) Nature Communications, 13 (1), art. no. 5317 DOI: 10.1038/s41467-022-32958-x
Associate Scientist
Andrew Papanastasiou*
Research scientist
Eva Freckmann*
Research scientist
Daniel Muzatko*
Research scientist
Shikhar Asthana*
Research scientist
Lucas Zeiger*
Graduate student
Britt van Abeelen*
Graduate student
Ekansh Chauhan*
Graduate student
Jennifer Muscat
I am a PhD student that joined the Computational Biology group in October 2024. I amusing spatial data to identify markers associated with progression from early-stage pancreatic lesions to pancreatic ductal andenocarcinoma. My research interests centre on improving detection of pre-malignant lesions at high risk of progression, with the aim of supporting timely clinical prevention of cancer. I am originally from Malta, but have completed my university studies in pharmacology and bioinformatics in the UK. Outside of science, I have a great interest in travelling and exploring the world, as well as reading, exercising, and hiking in my free time.
Graduate student
Joshua Roche*
Graduate student


